Legal & General Group PLC Kala Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.25 - $11.7 $979 - $45,817	-3,916 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$0.3 - $1.31 $227 - $994	-759 Reduced 16.24%	3,916 $1,000
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $91,967 - $217,232	-79,282 Reduced 94.43%	4,675 $6,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $5.43 $181,948 - $377,091	69,446 Added 478.57%	83,957 $220,000
Q2 2021 Aug 12, 2021	BUY	$5.06 - $8.15 $430 - $692	85 Added 0.59%	14,511 $77,000
Q1 2021 May 17, 2021	SELL	$6.24 - $9.58 $1,747 - $2,682	-280 Reduced 1.9%	14,426 $97,000
Q3 2020 Nov 13, 2020	SELL	$7.5 - $11.11 $12,525 - $18,553	-1,670 Reduced 10.2%	14,706 $111,000
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $108,456 - $179,545	13,020 Added 387.96%	16,376 $172,000
Q1 2020 May 14, 2020	SELL	$3.83 - $8.79 $4,634 - $10,635	-1,210 Reduced 26.5%	3,356 $30,000
Q4 2019 Feb 13, 2020	BUY	$3.36 - $4.81 $1,394 - $1,996	415 Added 10.0%	4,566 $17,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $8.8 $6,872 - $12,267	1,394 Added 50.56%	4,151 $27,000
Q1 2019 May 15, 2019	BUY	$5.19 - $8.97 $4,157 - $7,184	801 Added 40.95%	2,757 $23,000
Q2 2018 Aug 10, 2018	SELL	$13.3 - $17.49 $7,315 - $9,619	-550 Reduced 21.95%	1,956 $27,000
Q1 2018 May 17, 2018	BUY	$12.26 - $18.98 $8,079 - $12,507	659 Added 35.68%	2,506 $40,000
Q4 2017 Feb 13, 2018	BUY	$13.68 - $23.17 $25,266 - $42,794	1,847	1,847 $35,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.